Expert clinical management of autoimmune hepatitis in the real world

Autor: R. Liberal, Y. S. de Boer, R. J. Andrade, G. Bouma, G. N. Dalekos, A. Floreani, D. Gleeson, G. M. Hirschfield, P. Invernizzi, M. Lenzi, A. W. Lohse, G. Macedo, P. Milkiewicz, B. Terziroli, B. van Hoek, J. M. Vierling, M. A. Heneghan, on behalf of the International Autoimmune Hepatitis Group (IAIHG), A. Pares, A. J. Montano-Loza, A. Granito, A. E. Kremer, C. Schramm, C. Lammert, E. L. R. Cancado, E. Bjornsson, F. Lammert, G. M. Hirschflield, H. Hofer, I. Mackay, J. Neuberger, J. P. H. Drenth, C. M. J. van Nieuwkerk, L. Muratori, M. Swain, M. Heneghan, M. Zeniya, O. Chazouilleres, P. Gines, R. Chapman, T. Berg, H. van Buuren, X. Ma

Publikováno v: Liberal, R, de Boer, Y S, Andrade, R J, Bouma, G, Dalekos, G N, Floreani, A, Gleeson, D, Hirschfield, G M, Invernizzi, P, Lenzi, M, Lohse, A W, Macedo, G, Milkiewicz, P, Terziroli, B, van Hoek, B, Vierling, J M, Heneghan, M, Pares, A, Montano-Loza, A J, Granito, A, Kremer, A E, Floreani, A, Lohse, A W, van Hoek, B, Terziroli, B, Schramm, C, Lammert, C, Cancado, E L R, Bjornsson, E, Lammert, F, Dalekos, G N, Bouma, G, Hirschflield, G M, Macedo, G, Hofer, H, Mackay, I, Neuberger, J, Vierling, J M, Drenth, J P H, van Nieuwkerk, C M J, Muratori, L, Lenzi, M, Swain, M, Heneghan, M, Zeniya, M, Chazouilleres, O, Gines, P, Milkiewicz, P, Andrade, R J, Ma, X & the International Autoimmune Hepatitis Group (IAIHG) 2017, ' Expert clinical management of autoimmune hepatitis in the real world ', Alimentary Pharmacology and Therapeutics, vol. 45, no. 5, pp. 723-732 . https://doi.org/10.1111/apt.13907
Alimentary Pharmacology and Therapeutics, 45(5), 723-732
Alimentary Pharmacology & Therapeutics, 45, 723-732
Alimentary Pharmacology & Therapeutics, 45, 5, pp. 723-732

none 55 si First published: 22 December 2016 Background: High-quality data on the management of autoimmune hepatitis (AIH) are scarce. Despite published guidelines, management of AIH is still expert based rather than evidence based. Aim: To survey ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91175f447c75f0806a630fa90b826e1
https://hdl.handle.net/2066/169664

Oral calcium phosphate: a new therapy for Crigler-Najjar disease?

Autor: Maarten Sinaasappel, J. A. Rammeloo, R.P.J. Oude Elferink, C. N. Van Der Veere, R. van der Meer, Plm Jansen, H. Van Der Sijs, C. M. J. Van Nieuwkerk, P.H. Goyens

Publikováno v: Gastroenterology, 112(2), 455-462. W.B. Saunders Ltd
Gastroenterology, 112, 455-462. W.B. Saunders Ltd

BACKGROUND & AIMS: Calcium phosphate binds unconjugated bilirubin in vitro, and dietary calcium phosphate supplementation reduces the serum bilirubin level in rats with hereditary unconjugated hyperbilirubinemia (Gunn rats). The aim of this study was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9429211bcd3b8ef7cd408e96fa709f77
https://dare.uva.nl/personal/pure/en/publications/oral-calcium-phosphate-a-new-therapy-for-criglernajjar-disease(c98f3e38-ae41-459e-aeb2-7c52ac1be1e2).html

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

Autor: A M C, Baven-Pronk, M J, Coenraad, H R, van Buuren, R A, de Man, K J, van Erpecum, M M H, Lamers, J P H, Drenth, A P, van den Berg, U H, Beuers, J, den Ouden, G H, Koek, C M J, van Nieuwkerk, G, Bouma, J T, Brouwer, B, van Hoek

Publikováno v: Alimentary pharmacologytherapeutics. 34(3)

Treatment failure occurs in 20% of autoimmune hepatitis patients on prednisolone and azathioprine (AZA). There is no established second line treatment.To assess the efficacy of mycophenolate mofetil as second line treatment after AZA-intolerance or A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bd90f1498d6bc42cb95b74302bfd969d
https://pubmed.ncbi.nlm.nih.gov/21851370

Genotype distribution amongst hepatitis C patients in The Netherlands

Autor: M J, de Vries, B, te Rijdt, C M J, van Nieuwkerk

Publikováno v: The Netherlands journal of medicine. 64(4)

The prevalence of the genotypes of the hepatitis C virus (HCV) differs according to geographical location. In the United States and in European countries, the majority of patients are infected with genotype 1, 2 or 3. There is a lack of data on the d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1e2fa623b0ccdc8b89633f5406f5fdd6
https://pubmed.ncbi.nlm.nih.gov/16609154

Regulation of mdr2 P-glycoprotein expression by bile salts

Autor: Albert K. Groen, C. M. G. Frijters, M. J. A. Van Wijland, R. P. J. Oude Elferink, Roel Ottenhoff, C. M. J. Van Nieuwkerk

Publikováno v: Biochemical journal, 321(2), 389-395. Portland Press Ltd.

The phosphatidyl translocating activity of the mdr2 P-glycoprotein (Pgp) in the canalicular membrane of the mouse hepatocyte is a rate-controlling step in the biliary secretion of phospholipid. Since bile salts also regulate the secretion of biliary

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0895b9808d363afa9dab724ad4a89f1b
https://pure.amc.nl/en/publications/regulation-of-mdr2-pglycoprotein-expression-by-bile-salts(86a6fc95-e481-4652-aec1-ad14cefd7d71).html